Fluorescence-guided surgery using methylene blue to improve identification of metastatic small intestinal neuroendocrine tumours
Br J Surg
.
2023 Apr 12;110(5):541-544.
doi: 10.1093/bjs/znad043.
Authors
Hidde A Galema
1
2
,
Tessa M van Ginhoven
1
,
Gaston J H Franssen
1
,
Johannes Hofland
3
,
Claire G O T Bouman
4
,
Cornelis Verhoef
1
,
Alexander L Vahrmeijer
5
,
Merlijn Hutteman
5
6
,
Denise E Hilling
1
5
,
Stijn Keereweer
2
Affiliations
1
Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
2
Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
3
Department of Internal Medicine, Division of Endocrinology, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
4
Department of Anaesthesiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
5
Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
6
Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
PMID:
36861217
PMCID:
PMC10364524
DOI:
10.1093/bjs/znad043
No abstract available
MeSH terms
Fluorescence
Humans
Intraoperative Care
Methylene Blue
Neuroendocrine Tumors*
Surgery, Computer-Assisted*
Substances
Methylene Blue